WASHINGTON -- Eli Lilly & Co. won approval Thursday to sell the antidepressant Cymbalta, its second-biggest drug, as a treatment for pain. The Food and Drug Administration cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back ... Read more »
Panel recommends Cymbalta for chronic pain – United Press International
WASHINGTON, Aug. 20 (UPI) -- The makers of the antidepressant drug Cymbalta have narrowly won approval from a U.S Read more »
FDA questions wider approval of Eli Lilly’s Cymbalta – Victorville Daily Press
WASHINGTON • Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain. The Food and Drug Administration on Tuesday posted ... Read more »
